179 related articles for article (PubMed ID: 16775163)
1. Joint National Cancer Institute-Food and Drug Administration workshop on research strategies, study designs, and statistical approaches to biomarker validation for cancer diagnosis and detection.
Maruvada P; Srivastava S
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1078-82. PubMed ID: 16775163
[TBL] [Abstract][Full Text] [Related]
2. Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations.
Dobbin KK; Cesano A; Alvarez J; Hawtin R; Janetzki S; Kirsch I; Masucci GV; Robbins PB; Selvan SR; Streicher HZ; Zhang J; Butterfield LH; Thurin M
J Immunother Cancer; 2016; 4():77. PubMed ID: 27891226
[TBL] [Abstract][Full Text] [Related]
3. AACR-FDA-NCI cancer biomarkers collaborative.
Yu LR; Veenstra TD
Expert Rev Mol Diagn; 2007 Sep; 7(5):507-9. PubMed ID: 17892359
[TBL] [Abstract][Full Text] [Related]
4. Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.
Tahara H; Sato M; Thurin M; Wang E; Butterfield LH; Disis ML; Fox BA; Lee PP; Khleif SN; Wigginton JM; Ambs S; Akutsu Y; Chaussabel D; Doki Y; Eremin O; Fridman WH; Hirohashi Y; Imai K; Jacobson J; Jinushi M; Kanamoto A; Kashani-Sabet M; Kato K; Kawakami Y; Kirkwood JM; Kleen TO; Lehmann PV; Liotta L; Lotze MT; Maio M; Malyguine A; Masucci G; Matsubara H; Mayrand-Chung S; Nakamura K; Nishikawa H; Palucka AK; Petricoin EF; Pos Z; Ribas A; Rivoltini L; Sato N; Shiku H; Slingluff CL; Streicher H; Stroncek DF; Takeuchi H; Toyota M; Wada H; Wu X; Wulfkuhle J; Yaguchi T; Zeskind B; Zhao Y; Zocca MB; Marincola FM
J Transl Med; 2009 Jun; 7():45. PubMed ID: 19534815
[TBL] [Abstract][Full Text] [Related]
5. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
6. Biomarker research with prospective study designs for the early detection of cancer.
Pesch B; Brüning T; Johnen G; Casjens S; Bonberg N; Taeger D; Müller A; Weber DG; Behrens T
Biochim Biophys Acta; 2014 May; 1844(5):874-83. PubMed ID: 24361552
[TBL] [Abstract][Full Text] [Related]
7. Standards in molecular diagnostics for the discovery and validation of clinically useful cancer biomarkers.
Vydelingum NA; Sorbara L; Wagner P; Srivastava S
Expert Rev Mol Diagn; 2013 Jun; 13(5):421-3. PubMed ID: 23782249
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in molecular medicine: cancer detection and diagnosis.
Maruvada P; Wang W; Wagner PD; Srivastava S
Biotechniques; 2005 Apr; Suppl():9-15. PubMed ID: 16528918
[TBL] [Abstract][Full Text] [Related]
9. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.
Schully SD; Carrick DM; Mechanic LE; Srivastava S; Anderson GL; Baron JA; Berg CD; Cullen J; Diamandis EP; Doria-Rose VP; Goddard KA; Hankinson SE; Kushi LH; Larson EB; McShane LM; Schilsky RL; Shak S; Skates SJ; Urban N; Kramer BS; Khoury MJ; Ransohoff DF
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25688116
[TBL] [Abstract][Full Text] [Related]
10. The early detection research network: 10-year outlook.
Srivastava S
Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in biosensor development for the detection of cancer biomarkers.
Jayanthi VSPKSA; Das AB; Saxena U
Biosens Bioelectron; 2017 May; 91():15-23. PubMed ID: 27984706
[TBL] [Abstract][Full Text] [Related]
12. Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer.
Malik SM; Pazdur R; Abrams JS; Socinski MA; Sause WT; Harpole DH; Welch JJ; Korn EL; Ullmann CD; Hirsch FR
J Thorac Oncol; 2014 Oct; 9(10):1443-8. PubMed ID: 25521397
[TBL] [Abstract][Full Text] [Related]
13. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.
Skates SJ; Gillette MA; LaBaer J; Carr SA; Anderson L; Liebler DC; Ransohoff D; Rifai N; Kondratovich M; Težak Ž; Mansfield E; Oberg AL; Wright I; Barnes G; Gail M; Mesri M; Kinsinger CR; Rodriguez H; Boja ES
J Proteome Res; 2013 Dec; 12(12):5383-94. PubMed ID: 24063748
[TBL] [Abstract][Full Text] [Related]
14. Biomarker definitions and their applications.
Califf RM
Exp Biol Med (Maywood); 2018 Feb; 243(3):213-221. PubMed ID: 29405771
[TBL] [Abstract][Full Text] [Related]
15. Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005.
Barker PE; Wagner PD; Stein SE; Bunk DM; Srivastava S; Omenn GS
Clin Chem; 2006 Sep; 52(9):1669-74. PubMed ID: 16840585
[TBL] [Abstract][Full Text] [Related]
16. Cancer Proteomics and the Elusive Diagnostic Biomarkers.
Bradshaw RA; Hondermarck H; Rodriguez H
Proteomics; 2019 Nov; 19(21-22):e1800445. PubMed ID: 31172665
[TBL] [Abstract][Full Text] [Related]
17. Memorandum of understanding between the Food and Drug Administration and the National Institutes of Health's National Institute of Dental Research--FDA. Notice.
Fed Regist; 1998 Jun; 63(105):30002-5. PubMed ID: 10180274
[TBL] [Abstract][Full Text] [Related]
18. The US Food and Drug Administration perspective on cancer biomarker development.
Gutman S; Kessler LG
Nat Rev Cancer; 2006 Jul; 6(7):565-71. PubMed ID: 16794639
[TBL] [Abstract][Full Text] [Related]
19. Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.
Butterfield LH; Palucka AK; Britten CM; Dhodapkar MV; Håkansson L; Janetzki S; Kawakami Y; Kleen TO; Lee PP; Maccalli C; Maecker HT; Maino VC; Maio M; Malyguine A; Masucci G; Pawelec G; Potter DM; Rivoltini L; Salazar LG; Schendel DJ; Slingluff CL; Song W; Stroncek DF; Tahara H; Thurin M; Trinchieri G; van Der Burg SH; Whiteside TL; Wigginton JM; Marincola F; Khleif S; Fox BA; Disis ML
Clin Cancer Res; 2011 May; 17(10):3064-76. PubMed ID: 21558394
[TBL] [Abstract][Full Text] [Related]
20. Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.
Rodriguez H; Tezak Z; Mesri M; Carr SA; Liebler DC; Fisher SJ; Tempst P; Hiltke T; Kessler LG; Kinsinger CR; Philip R; Ransohoff DF; Skates SJ; Regnier FE; Anderson NL; Mansfield E;
Clin Chem; 2010 Feb; 56(2):237-43. PubMed ID: 20007859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
